BioCryst
+$0.30 (+1.86%) As of 4:14 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioCryst and other ETFs, options, and stocks.
About BCRX
BioCryst Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the development and discovery of novel, oral, and small-molecule medicines. It focuses on the oral treatments for rare diseases in which significant unmet medical needs exist and an enzyme plays the key role in the biological pathway of the disease.
CEO
Jon P. Stonehouse
Employees
246
Headquarters
Durham, North Carolina
Founded
1986
BCRX Key Statistics
Market Cap
2.97B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.76M
High Today
$16.56
Low Today
$16.13
Open Price
$16.15
Volume
888.36K
52 Week High
$17.74
52 Week Low
$3.30
BCRX News
Analyst Ratings
82%
of 11 ratings
Buy
81.8%
Hold
18.2%
Sell
0%
BCRX Earnings
-$0.36
-$0.24
-$0.12
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 5, Pre-Market